Clinical study of preoperative enhanced computed tomography combined with contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044494

Enrollment

Unknown

Registered

2021-03-23

Start date

2021-03-13

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Gold Standard:Postoperative pathological results

Index test:Enhanced&#32

CT&#32

combined&#32

with&#32

contrast-enhanced&#32

ultrasound

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: A. Patients diagnosed with hepatocellular carcinoma with hepatectomy; B. Routine preoperative enhanced CT and contrast-enhanced ultrasound examination; C. Patients diagnosed with hepatocellular carcinoma with hepatectomyRoutine pathological examination was performed after operation.

Exclusion criteria

Exclusion criteria: Diagnosis of metastatic liver cancer.

Design outcomes

Primary

Measure	Time frame
microvascular invasion;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactJiangfa Li

Affiliated Hospital of Guilin Medical College

247546160@qq.com+86 0773-2824373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026